Hospital Value Analysis Committee Medical Device Launch Email
Create a persuasive launch email to hospital Value Analysis Committees highlighting clinical efficacy and health economics.
Deploy this template when launching a newly approved medical device or diagnostic to hospital procurement committees. It balances clinical data with total cost-of-care benefits to secure formulary review.
Role: Executive Health Economics and Market Access (HEOR) Director specializing in MedTech hospital commercialization.
Context
- Medical device and indication: {{device_name_and_indication}}
- Economic value metric: {{hospital_cost_saving_metric}}
- Clinical efficacy data: {{clinical_efficacy_data}}
- Target hospital tier: {{target_hospital_tier}}
- Reimbursement status: {{reimbursement_coding_status}}
- Standard of care benchmark: {{comparative_standard_of_care}}
Task
Author a high-stakes, data-driven launch email targeted at hospital Value Analysis Committee (VAC) chairs and procurement directors to secure an agenda slot for formulary evaluation and commercial adoption.
Method
- Review {{device_name_and_indication}} and position its value proposition specifically for hospital executives at {{target_hospital_tier}}.
- Contrast clinical outcomes from {{clinical_efficacy_data}} against the current standard of care defined in {{comparative_standard_of_care}}.
- Translate clinical gains into budget impact, emphasizing {{hospital_cost_saving_metric}} such as length of stay reduction, readmission penalties, or procedural throughput.
- Clarify billing and coding pathway utilizing {{reimbursement_coding_status}} to remove payment ambiguity for hospital finance leads.
- Draft a subject line strategy optimized for hospital CFOs, Chief Medical Officers, and Supply Chain Directors.
- Construct the core email body balancing clinical evidence, health economics, and operational risk mitigation.
- Detail a friction-free evaluation path, proposing a structured trial evaluation or value dossier review meeting.
Constraints
- MUST maintain compliance with FDA/MDR promotional guidelines regarding approved labeling and on-label claims.
- MUST NOT make generalized pricing claims without explicit reference to health economic models.
- Tone must be executive, analytical, data-centric, and commercially rigorous.
- Word count must stay between 300 and 500 words to ensure C-suite readability.
Output format
- Subject Line Options: 3 targeted alternatives (Economic Hook, Clinical Hook, Hybrid Hook)
- Value Analysis Committee Email Body:
- Executive Summary & Regulatory Clearance
- Clinical Differentiation vs. {{comparative_standard_of_care}}
- Economic Impact & Budget Predictability
- Coding & Coverage Overview
- Proposed Actionable Next Step
- Supporting Attachment Brief: 3-4 bullet points describing materials to append (e.g., Budget Impact Model overview).
Self-review
- Ensure the trade-off between clinical efficacy and financial return is explicitly articulated.
- Verify all variables are seamlessly woven into the body text.
- Check that the proposed call to action offers a low-friction review process for hospital committee members.
Explicit role, a named task, and discrete steps the model can follow.
Background, inputs and variables the model needs before it starts.
Hard boundaries — what the model must and must not do.
A named, field-level shape for the response.
Ordered work items that force analysis before an answer.
Length and structure that travel across frontier models.
Signal density — instruction weight without padding.
Documented variables so the scaffold adapts to new inputs.
Quality bar, assumptions and behaviour when inputs are thin.
How much real usage the template has behind it.